Formoterol
Back to searchMolecule Structure
Scientific Name
Formoterol
Description of the Drug
Formoterol is an inhaled long-acting beta2-adrenergic receptor agonist used as a bronchodilator in the management of asthma and COPD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00983
http://www.drugbank.ca/drugs/DB00983
Brand Name(s)
Not Available
Company Owner(s)
Astrazeneca Ab, Mylan Specialty Lp, Astrazeneca Lp, Novartis Pharmaceuticals Corp, Organon Llc, Astrazeneca Pharmaceuticals Lp, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL349579 | ||||
| PharmGKB | PA134687907 | ||||
| Human Metabolome Database | HMDB0015118 | ||||
| DrugBank | DB00983 | ||||
| PubChem: Thomson Pharma | 14875897 | ||||
| PubChem | 3410 | ||||
| DrugCentral | 1239 | ||||
| Guide to Pharmacology | 3465 | ||||
| rxnorm | FORMOTEROL | FORADIL | FORMOTEROL FUMARATE | PERFOROMIST | FORMOTEROL FUMARATE DIHYDRATE |
| KEGG Ligand | C07805 | ||||
| ChEBI | 63082 |
